Roche’s Elecsys pTau217 blood test secures CE mark for Alzheimer’s
May 13, 2026
The CE mark was granted based on data from retrospective studies in real-world early cognitive decline population.
The CE mark was granted based on data from retrospective studies in real-world early cognitive decline population.
Researchers at Rice University, in collaboration with The University of Texas MD Anderson Cancer Center and clinical partners, have reported results from a first-in-human trial evaluating a novel cell-based platform for localized delivery of interleukin-2 (IL-2) in patients with advanced ovarian cancer.
A new way to detect the onset of heart and kidney disease far earlier than previously possible has been discovered by scientists. The breakthrough, published today in Nature Communications, reveals a novel method for identifying damage to the lining of microscopic blood vessels.
Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer. The technology, which aims to bring high-resolution, real-time diagnostics directly to the point of care, was recently described in a paper published in the Proceedings of the National Academy of Sciences.
Now, a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) has developed a new type of CAR T cell therapy that targets a protein found almost exclusively on leukemia cells and not on healthy cells.
Researchers at Washington University School of Medicine in St. Louis, showed that a stem cell transplant in which the donor cells have been genetically engineered to remove a particular protein helps prevent toxic side effects and potentially improves the effectiveness of therapies given after a transplant to help prevent cancer recurrence.
The US Food and Drug Administration (FDA) has cleared Bayesian Health’s continuous artificial intelligence (AI)-driven sepsis monitor, making the device the first of its kind to achieve this milestone.
A novel, noninvasive brain stimulation approach—known as transcranial temporal interference stimulation (TIs)—may offer a new way to treat motor symptoms in Parkinson’s disease without the need for surgery, according to a pilot study appearing in eBioMedicine. The technique, which uses overlapping electrical currents to selectively target deep brain regions, significantly improved movement in patients compared with a sham treatment when targeting the subthalamic nucleus.
Findings from a new study have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart condition with a prevalence of one in 500 people and a frequent cause of sudden cardiac death.
Researchers at the TechMed Center of the University of Twente have built a swallowable soft robot that samples stomach fluid and measures acidity in real time.